BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Emmes' Acquisition of Essex Management Boosts Its Technology Prowess to Help Solve Global Health Challenges

Biopharma APAC sat down with Matt Honan (MH), Vice president and global head of corporate development at Emmes and Ching Tian (CT), Chief In...

April 06, 2023 | Influencers

TransCure bioServices expands their team to lead the way in animal welfare

TransCure bioServices, a unique fee-for-service Humanized Mouse Preclinical CRO, has announced two new additions to their workforce to further improve thei...

April 04, 2023 | News

ABIONYX Pharma Unveils Ophthalmology Strategy and Positive Preclinical Results for Innovative Technologies.

Very promising preclinical results of the apoA-I biovector in an acute inflammation model Development of safe corticoids to limit traditional corticoid-...

April 01, 2023 | News

Remedium and Exothera partner on scale-up and demonstration runs for AAV2-FGF18

Remedium’s lead candidate is the only disease modifying gene therapy based on the clinically proven regenerative mechanism of FGF18. OA is the larges...

March 30, 2023 | News

Thermo Fisher Scientific Selected to Support National Institute of Health’s Blueprint MedTech program

The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, has been awarded a five-year contract to provide ...

February 21, 2023 | News

Beyond Traditional Placebo Controls in Rare Disease Clinical Trials

The Collaborative Trajectory Analysis Project (cTAP), a global coalition in rare disease, has announced evidence to support patient-centric alternativ...

February 08, 2023 | News

GenScript is increasing its capacity for producing cGMP sgRNA and non-viral DNA payloads in order to keep project wait times to a minimum.

How is GenScript planning to meet the growing demand for cell and gene therapies in 2023? GenScript is committed to advancing non-viral gene and cell ther...

February 01, 2023 | Influencers

Novotech Acquires European CRO, Strengthens Global Operations

The acquisition means biotech clients can access Novotech's unique and unparalleled suite of early to late-phase CRO services across Europe and the US, wit...

January 12, 2023 | News

Novotech Acquires US-based Drug Development Consulting Firm, CBR International

Novotech, the leading Asia Pacific centered biotech CRO today announced the acquisition of CBR International, a global product development, clinical oversi...

January 12, 2023 | News

Avance Clinical Celebrates GlobalReady Success as more than 40 Biotech Clients Enter Program

Avance Clinical made the announcement at Biotech Showcase 2023 where the team is taking meetings via PartnershipOne. "Given this successful early adoption ...

January 11, 2023 | News

Aurisco cooperates with Cytiva to build its first Oligo FlexFactory for commercial production

Located in Yangzhou of East China, Aurisco's new commercial manufacturing site is expected to produce 200 kilograms of oligonucleotides each year. ...

January 06, 2023 | News

Data Shows 50% of New Trials Have Sites in Asia Pacific

According to the new publication titled "State of the Global Biotech Landscape: Where the Opportunities Lie", demand for Asia Pacific trial sites is strong...

December 15, 2022 | News

Emmes (Global CRO) rapidly expands in India

Global CRO’s India office reports surging growth from Western, regional and local trial customers Emmes – a global, full-se...

October 28, 2022 | News

WuXi Biologics and Toregem BioPharma Sign MOU for Development of Anti-USAG-1 Antibody

Within the partnership, Toregem BioPharma will have access to WuXi Biologics' integrated CMC services in cell line development, cell banking and testing se...

October 12, 2022 | News

Stay Connected